Legato Capital Management LLC lowered its position in Maximus, Inc. (NYSE:MMS – Free Report) by 48.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,952 shares of the health services provider’s stock after selling 15,896 shares during the period. Legato Capital Management LLC’s holdings in Maximus were worth $1,463,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Farther Finance Advisors LLC grew its holdings in shares of Maximus by 69.0% in the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock worth $25,000 after acquiring an additional 116 shares during the period. Advisory Services Network LLC acquired a new stake in shares of Maximus in the 3rd quarter worth approximately $32,000. Cullen Frost Bankers Inc. acquired a new stake in shares of Maximus in the 3rd quarter worth approximately $38,000. Richardson Financial Services Inc. grew its holdings in shares of Maximus by 29.6% in the 4th quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock worth $39,000 after acquiring an additional 103 shares during the period. Finally, Canada Pension Plan Investment Board acquired a new stake in shares of Maximus in the 2nd quarter worth approximately $35,000. Institutional investors and hedge funds own 97.21% of the company’s stock.
Insider Transactions at Maximus
In related news, Director Jan Madsen sold 742 shares of the company’s stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the sale, the director owned 20,795 shares of the company’s stock, valued at approximately $1,502,438.75. This represents a 3.45% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.80% of the company’s stock.
Analyst Ratings Changes
View Our Latest Report on Maximus
Maximus Price Performance
MMS stock opened at $61.09 on Monday. Maximus, Inc. has a 1 year low of $56.92 and a 1 year high of $100.00. The company has a debt-to-equity ratio of 0.87, a quick ratio of 2.21 and a current ratio of 2.21. The stock’s 50 day moving average price is $65.48 and its 200 day moving average price is $78.05. The firm has a market cap of $3.21 billion, a P/E ratio of 9.15 and a beta of 0.60.
Maximus (NYSE:MMS – Get Free Report) last posted its earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.98 by $0.09. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The firm had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.32 billion. During the same quarter in the prior year, the company earned $2.01 EPS. Maximus’s revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, sell-side analysts expect that Maximus, Inc. will post 8.4 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Friday, May 15th will be paid a $0.33 dividend. The ex-dividend date of this dividend is Friday, May 15th. This represents a $1.32 dividend on an annualized basis and a yield of 2.2%. Maximus’s dividend payout ratio is presently 19.76%.
Maximus Company Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Featured Articles
- Five stocks we like better than Maximus
- The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
- 3 Rare Earth Stocks That Win No Matter What China Does Next
- Amylyx Stock: Why the Full Pipeline Story Matters
- Palantir and Dell Build an AI OS for the Paranoid
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
